XFOR
X4 Pharmaceuticals, Inc. - Common Stock (XFOR)
$58
About X4 Pharmaceuticals, Inc. - Common Stock (XFOR)
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Details
Daily high
$3.64
Daily low
$3.48
Price at open
--
52 Week High
$4.83
52 Week Low
$2.80
Market cap
354.9M
Dividend yield
-
Volume
933
Avg. volume
923,125
P/E ratio
-3.00
X4 Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$3.64
Daily low
$3.48
Price at open
--
52 Week High
$4.83
52 Week Low
$2.80
Market cap
354.9M
Dividend yield
-
Volume
933
Avg. volume
923,125
P/E ratio
-3.00